Okayama Saiseikai General Hospital

Mesorectal Excision With or Without Lateral Lymph Node Dissection for Clinical Stage II/III Lower Rectal Cancer (JCOG0212)

Shin Fujita, Junki Mizusawa, Yukihide Kanemitsu et al. · Annals of Surgery · 2017 · 436 citations · Full text

Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial

Erik A. Imel, Francis H. Glorieux, Michael P. Whyte et al. · The Lancet · 2019 · 347 citations · Full text

X-linked Hypophosphataemia, Pediatric Hematology, Hematology +2

A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial Evaluating the Efficacy of Burosumab, an Anti-FGF23 Antibody, in Adults With X-Linked Hypophosphatemia: Week 24 Primary Analysis

Karl Insogna, Karine Briot, Erik A. Imel et al. · Journal of Bone and Mineral Research · 2018 · 329 citations · Full text

Sclerostin, Human Growth, Immunology +21

Guidelines on the management and treatment of glucocorticoid-induced osteoporosis of the Japanese Society for Bone and Mineral Research: 2014 update

Yasuo Suzuki, Hajime Nawata, Satoshi Soen et al. · Journal of Bone and Mineral Metabolism · 2014 · 289 citations

Japanese Society, Bone Disease, Bone Health +6

2008 Japanese Society for Dialysis Therapy: Guidelines for Renal Anemia in Chronic Kidney Disease

Yoshiharu Tsubakihara, Shinichi Nishi, Takashi Akiba et al. · Therapeutic Apheresis and Dialysis · 2010 · 285 citations